HAEMONETICS CORP

HAEMONETICS CORP is a global medical technology company focused on improving healthcare quality, effectiveness, and efficiency. The company provides innovative solutions for critical medical needs, including hospital technologies to advance care standards and enhance patient outcomes, end-to-end plasma collection technologies to optimize plasma center operations, and products enabling blood centers to collect in-demand blood components. HAEMONETICS CORP manages its business through three principal reporting segments: Plasma, Blood Center, and Hospital. The Plasma segment includes plasma collection devices and disposables, donor management software, and supporting software solutions sold to plasma customers. The Blood Center segment encompasses blood collection and processing devices and disposables for plasma, red cells, and platelets. The Hospital segment is comprised of Interventional Technologies, which includes Vascular Closure, Sensor-Guided Technologies, and Esophageal Protection product lines, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage, and Transfusion Management product lines. The availability of products can vary by country or region due to local regulatory approval requirements, and applicable laws may restrict product sale, distribution, or use to, by, or on the order of a licensed healthcare practitioner.